Gain Therapeutics (GANX) Tax Rate (2020 - 2026)
Gain Therapeutics (GANX) posted Tax Rate of 2.28% for Q2 2026, up 32.53% on a QoQ basis from 3.37% in Q1 2026, and up 21.0% year-over-year from 1.88% in Q2 2025.
Powered by 
Analysis
Gain Therapeutics (GANX) Tax Rate (2020 - 2026) Analysis & Trends
Gain Therapeutics has reported Tax Rate for 7 years, with the latest figure at 2.28% in Q2 2026.
- On a quarterly basis, Tax Rate rose 21.0% year-over-year to 2.28% in Q2 2026; TTM through Jun 2026 was 17.91%, a 2163.0% increase from a year earlier, with the FY2025 full-year figure at 18.03%, up 2043.0% from the prior year.
- Tax Rate was 2.28% for Q2 2026 at Gain Therapeutics, up from 3.37% in the prior quarter.
- The five-year high for Tax Rate was 63.37% in Q4 2025, with the low at 11.6% in Q3 2025.
- Average Tax Rate over 5 years is 1.58%, with a median of 0.4% recorded in 2023.
- The largest YoY upside for Tax Rate was 7211 bps in 2025 against a maximum downside of 1135 bps in 2025.
- Over 5 years, Tax Rate stood at 1.7% in 2022, then surged by 83 bps to 0.29% in 2023, then tumbled by 2911 bps to 8.74% in 2024, then surged by 825 bps to 63.37% in 2025, then plunged by 104 bps to 2.28% in 2026.
- The last three Tax Rate figures came in at 2.28% (Q2 2026), 3.37% (Q1 2026), and 63.37% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | Gain Therapeutics | 73.54 Mn | 73.54 Mn | - | -2.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.28% |
| Mar 31, 2026 | -3.37% |
| Dec 31, 2025 | 63.37% |
| Sep 30, 2025 | -11.60% |
| Jun 30, 2025 | -2.49% |
| Mar 31, 2025 | -2.28% |
| Dec 31, 2024 | -8.74% |
| Sep 30, 2024 | -0.25% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.50% |
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | -0.46% |
| Jun 30, 2023 | -0.35% |
| Mar 31, 2023 | -0.33% |
| Dec 31, 2022 | -1.70% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | -0.18% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | 0.26% |
| Sep 30, 2021 | -0.11% |